A restrospective study on 6058 patients in which 2791 patients with obstetric surgeries, 668 patients with the ectopic pregnancy (23,93%) and 342 patients with the cystic ovary (12,25%) in the Institute of mother and infant protection and care was carried out. The results have shown that the application of endo surgery for patients with the ectopic pregnancy: 43,9%; for patients with the cystic ovary: 33,33%. The cystic seperation and conservation of the healthy ovary tube for the cystic ovary: 51,07%
Pregnancy, Ectopic ; therapeutics

A prospective study was conducted at Hung Vuong Hospital from 2002 to 2004 on total of 1423 ectopic pregnancy cases to find out determinants of operation methods, either by laparoscopy or laparotomy, in conservative treatment of unruptured ectopic pregnancy. 355 patients were enrolled in the study with 190 laparoscopic operations and 165 laparotomy operations. Factors favored to laparotomy included history of ectopic pregnancy, ectopic mass<30mm and serum o-hCG at the time of operation<1000 mUI/ml. Determinants for laparoscopic operation included maternal aged 24-35 years, blood loss<100 ml and the surgeons familiar to laparoscopy. Laparoscopy method had operation time shorter than laparotomy, and there is no difference between the two methods concerning persistent ectopic pregnancy
Pregnancy, Ectopic,Therapeutics

110 cases of unruptured ectopic pregnancy were treated, among them 61 cases (55,5%) with 1 dose of methotrexate, 40 with 2 doses (36,4) and 9 with 3 doses (8,1%). Successful rate reached 90,9% (84-95%). β- HCG took 13 (±10,3) days to return to negative point. It took 31,8 (±20,7) days for ectopic pregnant mass to disappear. Not any severe side effect was notified, except 5 cases of nausea. After treating and 12 months of follow up,47,8% of cases had got new pregnancy, among them,9,9% had reccured ectopic pregnancy. Methotrexat is an efficacious internal therapeutic for unrupted ectopic pregnancy
Methotrexate ; Therapeutics ; Pregnancy, Ectopic ; hospitals

Ectopic pregnancy is common disease. Currently, beside of operation and endoscopy, the treatment of ectopic pregnancy by methotrexate is considered as a revolution. This is conservative, non-invasive treatment with the high success. The risk of relapsed ectopic pregnancy was lower, the cost was lower than this of endoscopic surgery.
Pregnancy, Ectopic ; therapeutics ; Methotrexate ; Pharmaceutical Preparations

A clinical trial was conducted from 6/2001 to 5/2004 at Women hospital of Hai Phong to look for efficacy of Methotrexate (MTX) in medical treatment of unruptured ectopic pregnancies. 100 patients admitted the hospital due to unruptured ectopic pregnancies with βhCG > 100mUl/ml- <10.000mUl/ml. Tubal diameter < 3cm were enrolled in study. Treatment consisted of 50mg/m2 skin of MTX injected intramusculary and all patients were followed up by utrasound and βhCG after 48 hours and then 7 days. Injection was repeated if βhCG declined less than 15% of the initial level or increased at the 7th day after the first dose. Maximum doses of MTX used were 3 courses. 71 out of 100 patients (71%) were treated with one dose of MTX, 27 with two courses (27%), and two patients with 3 courses. Success rate was 83%. Serious side effects of MTX were note, unless 20 patients had mild side effects. Pregnancy rate after treatment reached 42.8% with recurrent ectopic pregnancy rate was 4.8%.
Methotrexate ; Pharmaceutical Preparations ; Therapeutics ; Pregnancy, Ectopic